Modern times call for modernized treatment strategies for advanced gastrointestinal stromal tumors

J Gastrointest Oncol. 2024 Aug 31;15(4):2013-2015. doi: 10.21037/jgo-24-501. Epub 2024 Aug 17.

Authors

Shruthi R Perati¹, Andrew M Blakely¹

Affiliation

¹ Surgical Oncology Program, National Cancer Institute/National Institutes of Health, Bethesda, MD, USA.

No abstract available

Keywords: Gastrointestinal stromal tumor (GIST); imatinib; ripretinib; sunitinib; tyrosine kinase inhibitor (TKI).

Publication types

Editorial
Comment